abstract |
bispecific dll3-cd3 antibodies. the present invention relates to new dll3 / cd3 binding proteins. the invention also relates to nucleic acids that encode such proteins; methods for preparing such proteins; host cells that express or are capable of expressing such proteins; to compositions comprising such proteins; and the uses of such proteins or compositions, in particular for therapeutic purposes in the field of cancerous diseases. |